We are excited to announce our investment in IgniteData's Series A financing as they continue to enable real-time complex clinical trial data transfer from EHR to EDC systems!
IgniteData is pleased to announce the close of our Series A funding round, led by FCA Venture Partners with continued participation from SpringTide Ventures and @OncologyVentures. This investment will accelerate the expansion of our global research site network and advance our flagship platform, Archer, which enables real-time, automated transfer of complex clinical trial data from EHR to EDC systems and data warehouses. Already in use at leading cancer centers worldwide, Archer is delivering measurable improvements in trial speed, data quality, and collaboration between sites and sponsors. With this funding, we are positioned to scale internationally, expand into new data domains, and continue setting the standard for intelligent clinical trial data automation. Read the full release via the link in first comment. Zach Taft, MBA Richard Yeatman Dan Hydes Chin Weerappuli, MBA